FFA
MIRM icon

Farther Finance Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Farther Finance Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.76K Sell
44
-5
-10% -$522 ﹤0.01% 5153
2026
Q2 		$5.74K Sell
49
-60
-55% -$6.02K ﹤0.01% 4732
2026
Q1 		$10.3K Buy
109
+75
+221% +$7.05K ﹤0.01% 4087
2025
Q4 		$2.69K Buy
34
+17
+100% +$1.22K ﹤0.01% 4574
2025
Q3 		$1.25K Buy
17
+11
+183% +$699 ﹤0.01% 4306
2025
Q2 		$305 Buy
6
+3
+100% +$134 ﹤0.01% 4134
2025
Q1 		$132 Hold
3
– – ﹤0.01% 4030
2024
Q4 		$124 Hold
3
– – ﹤0.01% 3752
2024
Q3 		$117 Hold
3
– – ﹤0.01% 3755
2024
Q2 		$102 Buy
+3
New +$79 ﹤0.01% 3597

Other funds holding MIRM

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's MIRM Position: Q3 2026 in Review

Farther Finance Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 10% in Q3 2026, selling an estimated $522 and leaving 44 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #5153.

Farther Finance Advisors first reported a position in MIRM in Q2 2024 and has held it in 10 quarters since. The position peaked at $10.3K in Q1 2026. 6 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Farther Finance Advisors held 44 shares of Mirum Pharmaceuticals worth $3.76K as of Q3 2026.
  • Farther Finance Advisors sold 5 Mirum Pharmaceuticals shares in Q3 2026, an estimated $522.
  • Mirum Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5153 holding.
  • Farther Finance Advisors first reported a position in Mirum Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
  • Farther Finance Advisors's Mirum Pharmaceuticals position peaked at $10.3K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.